Related Experiment Video
Updated: Jun 3, 2026

07:36
Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Anti-inflammatory diterpene from Thyrsanthera suborbicularis.
Piseth Khiev1, Sei-Ryang Oh, Hee-Sung Chae
1University of Science & Technology, Daejeon, Korea.
Chemical & Pharmaceutical Bulletin
|March 5, 2011
Summary
A new diterpene from Thyrsanthera suborbicularis, 19-hydroxy-1(10), 15-rosadiene, shows potent inhibition of nitric oxide production in activated mouse macrophages. This compound suppresses inducible nitric oxide synthase (iNOS) mRNA expression.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Immunology
Background:
- Thyrsanthera suborbicularis is a plant source of bioactive compounds.
- Nitric oxide (NO) plays a crucial role in inflammatory responses.
- Inhibiting excessive NO production is a therapeutic target for inflammatory diseases.
Purpose of the Study:
- To isolate and characterize bioactive compounds from Thyrsanthera suborbicularis.
- To evaluate the anti-inflammatory potential of isolated compounds, specifically their effect on nitric oxide production.
Main Methods:
- Bioactivity-guided fractionation of a n-hexane-soluble extract of Thyrsanthera suborbicularis.
- Structure elucidation of isolated compounds using NMR spectroscopy and mass spectrometry.
- In vitro assessment of inhibitory activity on nitric oxide production in lipopolysaccharide (LPS)-activated RAW264.7 mouse macrophages.
Main Results:
- A new rosane-type diterpene, 19-hydroxy-1(10), 15-rosadiene, was isolated and characterized.
- Three known compounds, taraxerol, acetyl aleuritolic acid, and spathulenol, were also identified.
- Compound 1 exhibited significant inhibitory activity against nitric oxide production with an IC(50) value of 2.91 µg/ml.
- The inhibitory mechanism involves the suppression of inducible nitric oxide synthase (iNOS) mRNA expression.
Conclusions:
- Thyrsanthera suborbicularis contains a novel diterpene with significant anti-inflammatory properties.
- 19-hydroxy-1(10), 15-rosadiene is a promising candidate for further investigation as a therapeutic agent for inflammatory conditions.
- The compound's ability to inhibit iNOS expression highlights its potential in modulating inflammatory pathways.